Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.

Bushara O, Devaro D, Ahn SS, Dourlain J, Farooq MS, Brunetti A, Chen S, Feldser D, Kucharczuk JC, Singhal S

Open source

DOI
10.3390/cancers17213540
Published
2025 Nov 1
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers17213540,
  title = {Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.},
  author = {Bushara O and Devaro D and Ahn SS and Dourlain J and Farooq MS and Brunetti A and Chen S and Feldser D and Kucharczuk JC and Singhal S},
  year = {2025},
  journal = {Cancers},
  doi = {10.3390/cancers17213540},
  url = {https://doi.org/10.3390/cancers17213540}
}

RIS

TY  - JOUR
TI  - Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.
AU  - Bushara O
AU  - Devaro D
AU  - Ahn SS
AU  - Dourlain J
AU  - Farooq MS
AU  - Brunetti A
AU  - Chen S
AU  - Feldser D
AU  - Kucharczuk JC
AU  - Singhal S
PY  - 2025
JO  - Cancers
DO  - 10.3390/cancers17213540
UR  - https://doi.org/10.3390/cancers17213540
ER  - 

APA

O, B., D, D., SS, A., J, D., MS, F., A, B., S, C., D, F., JC, K., & S, S. (2025). Characterizing the Clinical and Molecular Profile of SETD2-Mutated Lung Adenocarcinoma.. Cancers. https://doi.org/10.3390/cancers17213540

Source records